Prevalence of United States adults with triglycerides ≥ 135 mg/dL: NHANES 2007–2014
Open accessAbstract
n/a - brief communication.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the United States, >15 million patients with triglycerides ≥135 mg/dL are on statins.
“In the United States, there are at least 70 million patients with triglycerides ≥135 mg/dL, with >15 million of those on statins, and >7 million of those with LDL-C controlled to <100 mg/dL.”
From REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States (2020) · cites this paper as [17]
It is estimated that almost 5 million US patients fit the REDUCE-IT patient profile.
“It is estimated that there are almost 5 million US patients who fit the REDUCE-IT patient profile: statin-treated with diabetes mellitus or established cardiovascular disease who are ≥45 years of age with LDL-C <100 mg/dL.16,17”
From REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States (2020) · cites this paper as [17]
In the United States, there are at least 70 million patients with triglycerides ≥135 mg/dL.
“In the United States, there are at least 70 million patients with triglycerides ≥135 mg/dL, with >15 million of those on statins, and >7 million of those with LDL-C controlled to <100 mg/dL.”
From REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States (2020) · cites this paper as [17]
In the United States, >7 million patients with triglycerides ≥135 mg/dL have LDL-C controlled to <100 mg/dL.
“In the United States, there are at least 70 million patients with triglycerides ≥135 mg/dL, with >15 million of those on statins, and >7 million of those with LDL-C controlled to <100 mg/dL.”
From REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States (2020) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090 · see citing works
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812792 · Cited by 3,317 · see citing works
Self-citationSchwartz, G. G., Abt, M., Bao, W., DeMicco, D., Kallend, D., Miller, M., Mundl, H., & Olsson, A. G. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.03.544 · Cited by 272 · see citing works
Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis
Pedersen, S. B., Langsted, A., & Nordestgaard, B. G. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.6875 · Cited by 270 · see citing works
Jellinger, P. S., Handelsman, Y., Rosenblit, P. D., Bloomgarden, Z. T., Fonseca, V. A., GARBER, A., Grunberger, G., Guerin, C. K., Bell, D. H., Mechanick, J. I., et al. (2017) · Endocrine Practice · doi:10.4158/ep171764.gl · Cited by 205 · see citing works
Toth, P. P., Granowitz, C., Hull, M., Liassou, D., Anderson, A., & Philip, S. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008740 · Cited by 117 · see citing works
Self-citationFan, W., Philip, S., Granowitz, C., Toth, P. P., & Wong, N. D. (2019) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2018.11.008 · Cited by 67 · see citing works
Self-citationToth, P. P., Philip, S., HULL, M. L., & Granowitz, C. B. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.03.028 · Cited by 59 · see citing works
Self-citationPrevalence of US Adults With Triglycerides ≥135 mg/dL: NHANES 2007-2014
Philip, S., Fan, W., Granowitz, C. B., et al. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.04.041 · Cited by 3 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- [7]American Diabetes Association® issues critical updates to the 2019 standards of medical care in diabetes Arlington, VA 2019 http://www.diabetes.org/newsroom/press-releases/2019/ada-issues-critical-updates-to-2019-standards-of-care.html Accessed April 11, 2019
Cited by
Sorted by citations
REDUCE-IT USA: Results From the 3146 Patients Randomized in the United States
Bhatt, D. L., Miller, M., Brinton, E. A., Jacobson, T. A., Steg, P. G., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044440 · Cited by 136 · see citing works
Self-citation
- Authors
- Fan, W., Philip, S., Toth, P. P., Granowitz, C., & Wong, N. D.
- Affiliations
- University of California, Irvine (US)
- Amarin (United States) (US)
- Johns Hopkins University (US)
- Corresponding author
- Wong, Nathan D.
- Venue
- Cardiology Journal
- Publisher
- VM Media SP. zo.o VM Group SK
- Published
- 2019-11-06
- Volume
- 26
- Issue
- 5
- Pages
- 604-606
- ISSN
- 1897-5593 (ISSN-L)
- 1898-018X
- PMC
- PMC8084389
- OpenAlex
- W2987665527
- Cited by
- 6
- References
- 9
- Citations by year
- 2023: 2 · 2022: 1 · 2021: 2 · 2019: 1
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Cardiology Journal (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by-nc-nd)
- Funders
- Amarin Corporation
- Amarin Pharma
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Keywords
- hypertriglyceridemia, triglycerides, prevalence, adults, NHANES, dyslipidemia, cardiovascular risk
- MeSH terms
- Diabetes Mellitus, Humans, Cholesterol, LDL, Nutrition Surveys, Time Factors, Triglycerides, United States, Hypertriglyceridemia, Biomarkers, Prevalence, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
